[Mineral and bone disorders associated with chronic kidney disease]

Area of Science:

• Nephrology
• Rheumatology
• Bone Metabolism

Background:

• Chronic renal failure (CRF) frequently co-exists with osteoporosis.
• Rheumatologists require guidance on managing bone mineral disease in CRF patients.
• Current diagnostic and treatment strategies for bone disease in CRF need clarification.

Purpose of the Study:

• To review recent advances in diagnosing and treating bone mineral disease in patients with chronic renal failure.
• To provide practical guidelines for rheumatologists managing osteoporosis in the context of varying stages of CRF.
• To highlight the importance of multidisciplinary care, involving nephrologists, for advanced CRF cases.

Main Methods:

• Review of recent scientific literature and clinical practice guidelines.
• Analysis of diagnostic and therapeutic approaches based on CRF stage.
• Focus on the use of antiresorptive agents in well-selected CRF patients.

Main Results:

• Diagnosis and treatment of osteoporosis in stages I and II CRF are comparable to patients with normal renal function.
• Management in stage III CRF depends on specific test results.
• Advanced CRF necessitates coordinated care with nephrologists; antiresorptive agents may be used cautiously in select patients.

Conclusions:

• Early-stage CRF (I-II) management for bone disease mirrors standard osteoporosis treatment.
• Management strategies must be tailored to CRF stage, with advanced stages requiring specialist nephrology input.
• Careful patient selection allows for the potential use of antiresorptive therapies in advanced CRF.